ARTICLE | Clinical News
Sovaldi sofosbuvir/velpatasvir: Phase III data
September 28, 2015 7:00 AM UTC
Top-line data from the double-blind, placebo-controlled, international Phase III ASTRAL-1 trial in 740 patients with chronic HCV genotype 1, 2, 4, 5 or 6 infection showed that a fixed-dose oral combin...